Cargando…
Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy
SIMPLE SUMMARY: Richter Syndrome is the development of an aggressive lymphoma in patients affected by chronic lymphocytic leukemia, the most common leukemia in adults. This transformation occurs in 1–10% of chronic lymphocytic leukemia patients and represents an unmet clinical need due to its refrac...
Autores principales: | Mahmoud, Abdurraouf Mokhtar, Gaidano, Gianluca, Mouhssine, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954516/ https://www.ncbi.nlm.nih.gov/pubmed/36831361 http://dx.doi.org/10.3390/cancers15041015 |
Ejemplares similares
-
Richter Syndrome: From Molecular Pathogenesis to Druggable Targets
por: Mouhssine, Samir, et al.
Publicado: (2022) -
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome
por: Favini, Chiara, et al.
Publicado: (2022) -
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Gallazzi, Marco, et al.
Publicado: (2022) -
Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
por: Almasri, Mohammad, et al.
Publicado: (2022) -
The involvement of microRNA in the pathogenesis of Richter syndrome
por: Van Roosbroeck, Katrien, et al.
Publicado: (2019)